Maravai LifeSciences Holdings, Inc. Stock-Based Compensation
Maravai LifeSciences Holdings, Inc. (MRVI) reported Stock-Based Compensation of $16.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $10.21M, a 50.32% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.74M, a 35.18% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.93M, a 62.77% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $9.06M, a 30.61% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $30.17M, a 38.94% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $49.41M, a 42.87% increase from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $34.59M, a 85.26% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $18.67M, a 78.52% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $16.95M 10-Q · filed 2026-08-07 | $20.87M derived: sum of 3 quarters · filed 2026-08-07 | $29.93M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $6.74M 10-Q · filed 2026-05-08 | $10.67M derived: sum of 2 quarters · filed 2026-05-08 | $19.73M derived: sum of 3 quarters · filed 2026-05-08 | $26.51M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.98M derived: sum of 2 quarters · filed 2026-02-26 | $19.77M derived: sum of 3 quarters · filed 2026-08-07 | $30.17M 10-K · filed 2026-02-26 |
| 2025-09-30 | $9.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $15.85M derived: sum of 2 quarters · filed 2026-08-07 | $26.25M 10-Q · filed 2025-11-07 | $36.79M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $6.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $17.19M 10-Q · filed 2026-08-07 | $27.74M derived: sum of 3 quarters · filed 2026-08-07 | $40.79M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $10.40M 10-Q · filed 2026-05-08 | $20.95M derived: sum of 2 quarters · filed 2026-05-08 | $34.00M derived: sum of 3 quarters · filed 2026-05-08 | $47.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.59M derived: sum of 2 quarters · filed 2026-02-26 | $37.36M derived: sum of 3 quarters · filed 2026-02-26 | $49.41M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $26.81M derived: sum of 2 quarters · filed 2025-11-07 | $38.87M 10-Q · filed 2025-11-07 | $48.21M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $13.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $25.82M 10-Q · filed 2025-08-11 | $35.16M derived: sum of 3 quarters · filed 2026-02-26 | $45.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $12.06M 10-Q · filed 2025-05-12 | $21.40M derived: sum of 2 quarters · filed 2026-02-26 | $31.39M derived: sum of 3 quarters · filed 2026-02-26 | $40.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $9.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.33M derived: sum of 2 quarters · filed 2026-02-26 | $28.60M derived: sum of 3 quarters · filed 2026-02-26 | $34.59M 10-K · filed 2026-02-26 |
| 2023-09-30 | $9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $19.26M derived: sum of 2 quarters · filed 2024-11-12 | $25.25M 10-Q · filed 2024-11-12 | $31.24M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $9.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.26M 10-Q · filed 2024-08-08 | $21.25M derived: sum of 3 quarters · filed 2025-03-18 | $25.99M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | $5.99M 10-Q · filed 2024-05-09 | $11.98M derived: sum of 2 quarters · filed 2025-03-18 | $16.72M derived: sum of 3 quarters · filed 2025-03-18 | $21.03M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $10.73M derived: sum of 2 quarters · filed 2025-03-18 | $15.04M derived: sum of 3 quarters · filed 2025-03-18 | $18.67M 10-K · filed 2025-03-18 |
| 2022-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $9.05M derived: sum of 2 quarters · filed 2023-11-08 | $12.68M 10-Q · filed 2023-11-08 | $14.90M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $7.93M 10-Q · filed 2023-08-08 | $10.16M derived: sum of 3 quarters · filed 2024-02-29 | $13.73M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $3.63M 10-Q · filed 2023-05-09 | $5.86M derived: sum of 2 quarters · filed 2024-02-29 | $9.42M derived: sum of 3 quarters · filed 2024-02-29 | $11.81M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.80M derived: sum of 2 quarters · filed 2024-02-29 | $8.18M derived: sum of 3 quarters · filed 2024-02-29 | $10.46M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $5.95M derived: sum of 2 quarters · filed 2022-11-04 | $8.23M 10-Q · filed 2022-11-04 | $29.92M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.66M 10-Q · filed 2022-08-05 | $26.36M derived: sum of 3 quarters · filed 2023-02-28 | $28.21M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.28M 10-Q · filed 2022-05-06 | $23.97M derived: sum of 2 quarters · filed 2023-02-28 | $25.82M derived: sum of 3 quarters · filed 2023-02-28 | $26.40M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $23.55M derived: sum of 2 quarters · filed 2023-02-28 | $24.12M derived: sum of 3 quarters · filed 2023-02-28 | $24.63M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.42M derived: sum of 2 quarters · filed 2021-11-15 | $2.93M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $576.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.08M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $508.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $1.68M 10-K · filed 2022-03-01 |